Latest Insider Transactions at Aptinyx Inc. (APTX)
This section provides a real-time view of insider transactions for Aptinyx Inc. (APTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aptinyx Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aptinyx Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 13
2022
|
Joan W. Miller |
BUY
Open market or private purchase
|
Direct |
17,700
+50.0%
|
$35,400
$2.83 P/Share
|
Dec 06
2021
|
Norbert G Riedel EXECUTIVE CHAIRMAN OF THE BOD |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$200,000
$2.23 P/Share
|
Dec 02
2021
|
Ashish Khanna CFO AND CBO |
BUY
Open market or private purchase
|
Direct |
45,000
+9.68%
|
$90,000
$2.26 P/Share
|
Nov 12
2021
|
Robert J. Hombach |
BUY
Open market or private purchase
|
Direct |
74,600
+25.4%
|
$149,200
$2.4 P/Share
|
Nov 11
2021
|
Robert J. Hombach |
BUY
Open market or private purchase
|
Direct |
5,400
+3.6%
|
$10,800
$2.4 P/Share
|
May 17
2021
|
Norbert G Riedel EXECUTIVE CHAIRMAN OF THE BOD |
SELL
Payment of exercise price or tax liability
|
Direct |
127,274
-17.14%
|
$254,548
$2.53 P/Share
|
May 17
2021
|
Norbert G Riedel EXECUTIVE CHAIRMAN OF THE BOD |
BUY
Exercise of conversion of derivative security
|
Direct |
380,000
+33.85%
|
-
|
May 17
2021
|
Ashish Khanna CFO AND CBO |
SELL
Payment of exercise price or tax liability
|
Direct |
38,090
-9.22%
|
$76,180
$2.53 P/Share
|
May 17
2021
|
Ashish Khanna CFO AND CBO |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+23.94%
|
-
|
May 17
2021
|
Andrew Kidd PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
38,090
-27.38%
|
$76,180
$2.53 P/Share
|
May 17
2021
|
Andrew Kidd PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+48.3%
|
-
|
Oct 26
2020
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,333,333
+27.27%
|
$9,999,999
$3.0 P/Share
|
Jul 09
2020
|
Adams Street Partners LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
90,124
+24.67%
|
-
|
Jan 29
2020
|
Adams Street Partners LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
90,124
+32.74%
|
-
|
Jan 10
2020
|
Adams Street Partners LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+18.67%
|
$3,000,000
$3.0 P/Share
|
Jun 25
2018
|
Adams Street Partners LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+4.28%
|
$2,400,000
$16.0 P/Share
|
Jun 25
2018
|
Adams Street Partners LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,040,077
+33.2%
|
-
|